X-twitter Facebook-square Youtube Instagram Rss

Research

JOURNAL PUBLICATIONS

  1. Vorster M, Sathekge M. 18F-FDG PET/CT for prediction of response in breast cancer. InSeminars in Nuclear Medicine 2026 Jan 9. WB Saunders.
  2. Hadebe BP, Vorster M. The 21st Biennial congress of the South African Society of Nuclear Medicine conference report.
  3. Patel M, Harry L, Nxasana T, Gabela L, Masikane S, Pillay V, Hadebe B, Vorster M. 18 F‐FDG PET/CT Scans Versus 99m Tc‐MDP Bone Scintigraphy for Breast Cancer Patients with Bone Metastases.
  1. Vorster M, Grana CM, Travascio L, Sathekge MM. Alpha therapies: where and when is the future in neuroendocrine tumours?. Clinical and Translational Imaging. 2025 Mar 26:1-9.
  2. Hadebe B, Harry L, Gabela L, Nxasana T, Ndlovu N, Pillay V, Masikane S, Patel M, Mpanya D, Buccimaza I, Msimang M. Comparing 68Ga-Pentixafor, 18F-FDG PET/CT and Chemokine Receptor 4 Immunohistochemistry Staining in Breast Cancer: A Prospective Cross Sectional Study. Cancers. 2025 Feb 24;17(5):763.
  3. Mokoala KM, Nonjola L, Moeng T, Corbett C, Magwaza M, Dahlhoff G, Brown S, Vetter N, Vorster M, Sathekge MM. Alternative treatment for recurrent keloids: initial clinical experience with Rhenium-188 using a specialized device. European Journal of Nuclear Medicine and Molecular Imaging. 2025 Mar 12:1-8.
  4. Serumula W, Pillay V, Hadebe B, Vorster M. Fibroblast activation protein inhibitor (FAPI)-based theranostics. Pharmaceuticals. 2025 Apr 3;18(4):522.
  5. Vorster M, Grana CM, Travascio L, Sathekge MM. Alpha therapies: where and when is the future in neuroendocrine tumours?. Clinical and Translational Imaging. 2025 Aug;13(4):329-37.
  6. Mallum A, Tendwa MB, Saidu R, Swanson W, Phan P, Li H, Ngoma T, Avery S, Huq MS, Akudugu JM, Ngwa W. A comparative analysis of hypofractionated versus conventional radiotherapy for cervical cancer in a resource-limited setting: a prospective study. Frontiers in Oncology. 2025 Jun 4;15:1552346.
  7. Seppo SF, Mallum A, Tendwa M, Vorster M, Oboh EC, Myagmarsuren D, Bhatnagar AR, Czarnecki E, Akudugu J. The Impact of HIV Status on Vaginal Stenosis among Cervical Cancer Patients Receiving Radiotherapy in Low-And Middle-Income Countries: A Single Center Prospective Study. International Journal of Radiation Oncology, Biology, Physics. 2025 Sep 1;123(1):S187-8.
  8. Vorster M, Grana CM, Travascio L, Sathekge MM. Alpha therapies: where and when is the future in neuroendocrine tumours?. Clinical and Translational Imaging. 2025 Aug;13(4):329-37.
  9. Mokoala KM, Nonjola L, Moeng T, Corbett C, Magwaza M, Dahlhoff G, Brown S, Vetter N, Vorster M, Sathekge MM. Alternative treatment for recurrent keloids: initial clinical experience with Rhenium-188 using a specialized device. European Journal of Nuclear Medicine and Molecular Imaging. 2025 Jul;52(9):3151-8.
  10. Hadebe B, Gabela L, Nxasana T, Harry L, Setta M, Pillay V, Ndlovu N, Mkhize T, Patel M, Masikane S, Sathekge M. Preliminary results of first clinical experience with 68Ga-Pentixafor PET/CT imaging in gynecological malignancies, a comparison with 18F-FDG and CXCR4 immunohistochemistry.
  1. Vorster M, Sathekge M. Advances in PSMA alpha theragnostics. InSeminars in Nuclear Medicine 2024 Apr 23. WB Saunders.
  2. Lawal IO, Morgenstern A, Vorster M, Knoesen O, Mahapane J, Hlongwa KN, Maserumule LC, Ndlovu H, Reed JD, Popoola GO, Mokoala KM. Hematologic toxicity profile and efficacy of [225Ac] Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2022 Aug;49(10):3581-92.
  3. Hadebe B, Harry L, Gabela L, Masikane S, Patel M, Zwane S, Pillay V, Bipath P, Cebekhulu N, Nyakale N, Ramdass P. Chemokine Receptor-4 Targeted PET/CT Imaging with 68Ga-Pentixafor in Head and Neck Cancer—A Comparison with 18F-FDG and CXCR4 Immunohistochemistry. Diagnostics. 2024 Jun 28;14(13):1375.
  4. Gabela L, Mkhize T, Hadebe B, Harry L, Nxasana T, Ndlovu N, Pillay V, Masikane S, Patel M, Nyakale NE, Vorster M. A Comparison of 68Ga-PSMA PET/CT-Based Split Renal Function with 99mTc-MAG3 Renography in Patients with Metastatic Castration-Resistant Prostate Carcinoma Treated with 177Lu-PSMA. Diagnostics. 2024 Mar 8;14(6):578.
  5. Mallum A, Sibanda W, Tendwa MB, Akudugu JM, Ngwa W, Incrocci L, Vorster M. An Insight into the Current Status of the Radiotherapy Landscape in Africa: A Cross-sectional Survey Study on the Available Infrastructure and Human Resources. Medical Research Archives. 2024 Nov 29;12(11).
  6. Mallum A, Patel S, Olatunji E, Nnko G, Alabi A, Akudugu J, Eulade R, Joseph A, Ngoma M, Ngoma TA, Taiwo A. Treatment delays for cancer patients in Sub-Saharan Africa: South Africa as a microcosm. ecancermedicalscience. 2024 Aug 27;18:1747.
  7. Boshomane TM, Kgatle MM, Joseph F, Padayachy L, Bida M, Ebenhan T, Vorster M, Sathekge MM. The Clinical Utility of Molecular Imaging Using Nuclear Medicine Tools in the Management of All Stages of Adult Gliomas.
  8. Lawal IO, Morgenstern A, Knoesen O, Vorster M, Bruchertseifer F, Sathekge MM. Therapy of Castration-Resistant Prostate Cancer: Where Is the Place of 225Ac-PSMA?. InBeyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum 2024 Jan 6 (pp. 255-265). Cham: Springer International Publishing.
  9. Boshomane TM, Kgatle MM, Joseph F, Padayachy L, Bida M, Vorster M, machaba Sathekge M. The Potential Complementary Role of Imaging with 68Ga [68Ga-RGD] PET and MRI in Recurrent Adult Glioma.
  10. Hadebe B, Nxasana T, Harry L, Patel M, Ndlovu N, Msimang M, Sathekge M, Masikane S, Gabela L, Vorster M. [68Ga] Pentixafor PET/CT imaging in cervical cancer, a comparison with [18F] FDG.
  11. Lunj S, Smith TA, Reeves KJ, Currell F, Honeychurch J, Hoskin P, Choudhury A. Immune effects of α and β radionuclides in metastatic prostate cancer. Nature Reviews Urology. 2024 Nov;21(11):651-61.
  12. Lunj S, Smith TA, Reeves KJ, Currell F, Honeychurch J, Hoskin P, Choudhury A. Immune effects of α and β radionuclides in metastatic prostate cancer. Nature Reviews Urology. 2024 Nov;21(11):651-61.
  13. Elhaie M, Koozari A, Abedi I, Monsef A. Advancing Oncology through Imaging: Evaluating FDG-PET’s Role in Cancer Diagnosis and Staging. Frontiers in Biomedical Technologies. 2024 Sep 25.
  14. Nyakale N. Efficacy of a fixed low dose of radioactive iodine in the treatment of Graves’ disease in Sub-Saharan Africa. Hellenic Journal of Nuclear Medicine. 2024 Sep;27(3):176-80.
  1. Hadebe B, Harry L, Ebrahim T, Pillay V, Vorster M. The role of PET/CT in breast cancer. Diagnostics. 2023 Feb 6;13(4):597.
  2. Vorster M. Gallium-68 labelled radiopharmaceuticals for imaging inflammatory disorders. InSeminars in Nuclear Medicine 2023 Mar 1 (Vol. 53, No. 2, pp. 199-212). WB Saunders.
  3. Sathekge M, Bruchertseifer F, Vorster M, Lawal IO, Mokoala K, Reed J, Maseremule L, Ndlovu H, Hlongwa K, Maes A, Morgenstern A. 225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): Preliminary clinical findings. European journal of nuclear medicine and molecular imaging. 2023 Jun;50(7):2210-8.
  4. Mokoala KM, Lawal IO, Maserumule LC, Bida M, Maes A, Ndlovu H, Reed J, Mahapane J, Davis C, Van de Wiele C, Popoola G. Correlation between [68Ga] Ga-FAPI-46 PET imaging and HIF-1α immunohistochemical analysis in cervical cancer: proof-of-concept. Cancers. 2023 Aug 3;15(15):3953.

  5. Harry L, Vorster M, Pillay V, Hadebe B, Patel M, Gabela L, Masikane S, Nxasana L. Ga-68 DOTATATE Avid Ectopic Adrenocorticotropic Hormone Secreting Pulmonary Carcinoid Tumour detected on PET/CT. Journal of the Colleges of Medicine of South Africa. 2023;1(1):10.

  6. Harry L, Vorster M, Pillay V, Hadebe B, Patel M, Gabela L, Masikane S, Nxasana L. Ga-68 DOTATATE Avid Ectopic Adrenocorticotropic Hormone Secreting Pulmonary Carcinoid Tumour detected on PET/CT. Journal of the Colleges of Medicine of South Africa. 2023;1(1):10.
  7. Kgatle M, Das R, Lawal I, Boshomane T, Mokoala K, Gaspar C, Mbokazi L, Nkambule N, Gow V, Ndlovu H, Mzizi Y. The SARS-COV-2 Seroprevalence among Oncology Patients. Journal of Clinical Medicine. 2023 Jan 9;12(2):529.
  8. Mokoala KM, Lawal IO, Maserumule LC, Bida M, Maes A, Ndlovu H, Reed J, Mahapane J, Davis C, van de Wiele C, Popoola G. Correlation between [</SUP> 68<//SUP> Ga] Ga-FAPI-46 PET Imaging and HIF-1α Immunohistochemical Analysis in Cervical Cancer: Proof-of-Concept. Cancers. 2023 Aug 1;15(15).
  9. Kgatle M, Chalwe JM, Van Der Westhuizen D, Xu S, Damane BP, Mathebela P, Ueckermann V, Mayaphi S, Rodrigues HG, Moura-Alves P, Ndlovu H. Detection of Neutralizing Antibodies in COVID-19 Patients from Steve Biko Academic Hospital Complex: A Pilot Study. COVID. 2023 Jul 3;3(7):999-1010.
  10. Mpanya D, Sathekge M, Klug E, Damelin J, More S, Hadebe B, Vorster M, Tsabedze N. Gallium-68 fibroblast activation protein inhibitor positron emission tomography in cardiovascular disease. Frontiers in Nuclear Medicine. 2023 Jul 27;3:1224905.
  11. Mokoala KM, Lawal IO, Maserumule LC, Bida M, Maes A, Ndlovu H, Reed JD, Mahapane J, Davis C, Van de Wiele C, Popoola G. Correlation between [68Ga] Ga-FAPI-46 PET imaging and HIF-1 immunohistochemical analysis in cervical cancer: proof-of-concept.
  12. Mpanya D, Sathekge M, Klug E, Damelin J, More S, Hadebe B, Vorster M, Tsabedze N. Gallium-68 fibroblast activation protein inhibitor positron emission tomography in cardiovascular.
  13. Saranovic DS, Vorster M, Gambhir S, Pascual TN. PET/CT in tuberculosis. Clinicians’ Guides to Radionuclide Hybrid Imaging. 2023 Apr 21.
  14. Mokoala K, Lawal I, Maserumule L, Hlongwa K, Ndlovu H, Reed J, Mahapane J, Davis C, Bida M, Maes A, van de Wiele C. The Cancer-Associated Fibroblast and Hypoxia Nexus: Correlation between 68Ga-FAPI PET and Hypoxia Inducible Factor-1alpha Immunohistochemistry. World Journal of Nuclear Medicine. 2023 Jun;22(02):A028.
  15. Chonco B, Nxasana T, Harry L, Buthelezi-Zulu T, Gabela L, Sathekge M, Vorster M. [68Ga] Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in patients with locally advanced breast cancer-initial experience.
  16. Harry L, Pillay V, Hadebe B, Gabela L, Patel M, Masikane S, Nxasana T, Vorster M. 68Ga DOTATATE Avid Ectopic Adrenocorticotropic Hormone Secreting Pulmonary Carcinoid Tumor Detected on PET/CT. World Journal of Nuclear Medicine. 2023 Jun;22(02):A037.
  17. Harry L, Pillay V, Hadebe B, Gabela L, Patel M, Masikane S, Nxasana T, Vorster M. 68Ga DOTATATE Avid Ectopic Adrenocorticotropic Hormone Secreting Pulmonary Carcinoid Tumor Detected on PET/CT. World Journal of Nuclear Medicine. 2023 Jun;22(02):A037.
  18. Sathekge MM. Alfred O. Ankrah, MD,*, Andor WJM Glaudemans, MD, PhD, Alex Maes, MD, PhD,*, Christophe Van de Wiele, MD, PhD,*,|| Rudi AJO Dierckx, MD, PhD, Mariza Vorster, MD, PhD,* and. Semin Nucl Med.;48:108-30.
  19. Kgatle M, Chalwe JM, van der Westhuizen D, Xu S, Damane BP, Mathebela P, Ueckermann V, Mayaphi S, Rodrigues HG, Moura-Alves P. Detection of Neutralizing Antibodies in COVID-19 Patients from Steve Biko Academic Hospital Complex: A Pilot Study. COVID 2023, 3, 999–1010 [Internet]. 2023
  20. Kgatle M, Chalwe JM, van der Westhuizen D, Xu S, Damane BP, Mathebela P, Ueckermann V, Mayaphi S, Rodrigues HG, Moura-Alves P. Detection of Neutralizing Antibodies in COVID-19 Patients from Steve Biko Academic Hospital Complex: A Pilot Study. COVID 2023, 3, 999–1010 [Internet]. 2023
  21. Kgatle M, Chalwe JM, van der Westhuizen D, Xu S, Damane BP, Mathebela P, Ueckermann V, Mayaphi S, Rodrigues HG, Moura-Alves P. Detection of Neutralizing Antibodies in COVID-19 Patients from Steve Biko Academic Hospital Complex: A Pilot Study. COVID 2023, 3, 999–1010 [Internet]. 2023
  22. Mokoala KM, Lawal IO, Maserumule LC, Bida M, Maes A, Ndlovu H, Reed J, Mahapane J, Davis C, Van de Wiele C. Correlation between [68Ga] Ga-FAPI-46 PET Imaging and HIF-1α Immunohistochemical Analysis in Cervical Cancer: Proof-of-Concept. Cancers 2023, 15, 3953 [Internet]. 2023
  23. Laudicella R, Spataro A, Crocè L, Giacoppo G, Romano D, Davì V, Lopes M, Librando M, Nicocia A, Rappazzo A. Preliminary Findings of the Role of FAPi in Prostate Cancer Theranostics. Diagnostics 2023, 13, 1175 [Internet]. 2023
  1. Sathekge M, Bruchertseifer F, Vorster M, Lawal IO, Knoesen O, Mahapane J, Davis C, Mdlophane A, Maes A, Mokoala K, Mathabe K. mCRPC patients receiving 225Ac-PSMA-617 therapy in the post–androgen deprivation therapy setting: response to treatment and survival analysis. Journal of Nuclear Medicine. 2022 Oct 1;63(10):1496-502.
  2. Mallum A, Mkhize T, Akudugu JM, Ngwa W, Vorster M. The role of positron emission tomography and computed tomographic (PET/CT) imaging for radiation therapy planning: a literature review. Diagnostics. 2022 Dec 24;13(1):53.
  3. Lawal IO, Morgenstern A, Vorster M, Knoesen O, Mahapane J, Hlongwa KN, Maserumule LC, Ndlovu H, Reed JD, Popoola GO, Mokoala KM. Hematologic toxicity profile and efficacy of [225Ac] Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2022 Aug;49(10):3581-92.
  4. Sathekge M, Bruchertseifer F, Vorster M, Lawal IO, Knoesen O, Mahapane J, Davis C, Mdlophane A, Maes A, Mokoala K, Mathabe K. mCRPC patients receiving 225Ac-PSMA-617 therapy in the post–androgen deprivation therapy setting: response to treatment and survival analysis. Journal of Nuclear Medicine. 2022 Oct 1;63(10):1496-502.
  5. Grigoryan A, Bouyoucef S, Sathekge M, Vorster M, Orellana P, Estrada E, Mikhail Lette M, Morozova O, Pellet O, Paez D, Delgado Bolton RC. Development of nuclear medicine in Africa. Clinical and translational imaging. 2022 Apr 1:1-1.
  6. Hadebe B, Sathekge MM, Aldous C, Vorster M. Current status of 68Ga-Pentixafor in solid tumours. Diagnostics. 2022 Sep 2;12(9):2135.
  7. Lengana T, Lawal I, Van Rensburg CJ, Mokoala K, Moshokoa E, Mazibuko S, Van de Wiele C, Maes A, Vorster M, Sathekge MM. The diagnostic performance of 18F-PSMA-1007 PET/CT in prostate cancer patients with early recurrence after definitive therapy with a PSA< 10 ng/ml. Nuklearmedizin-NuclearMedicine. 2022 Apr;61(02):120-9.
  8. Pillay V, Hadebe B, Vorster M. Molecular imaging and theranostics in ovarian cancer: the role of nuclear medicine. Exon Publications. 2022 Sep 8:69-85.
  9. Bresser PL, Reed J, Sathekge MM, Vorster M. 68Ga‐nitroimidazole PET/CT imaging of hypoxia in tuberculosis: A case series. Journal of Medical Radiation Sciences. 2022 Dec;69(4):518-24.
  10. Bresser PL, Sathekge MM, Vorster M. PET/CT features of a novel gallium-68 labelled hypoxia seeking agent in patients diagnosed with tuberculosis: a proof-of-concept study. Nuclear Medicine Communications. 2022 Jul 1;43(7):787-93.
  11. Maserumule L, Mokoala K, Bruchertseifer F, Vorster M, Reed J, Lawal I, Morgenstern A, Sathekge M. Initial Experience of Lung Metastases Response to 225Ac-PSMA-617 Therapy in Metastatic Prostate Adenocarcinoma.
  12. Mokoala K, Lawal I, Nonjola L, Mokgoro N, Vorster M, Sathekge M. Superficial Brachytherapy of Nonmelanoma Skin Cancer with Rhenium-188. World Journal of Nuclear Medicine. 2022 Mar;21(01):A026.
  13. Maserumule LC, Mokoala KM, van de Wiele C, Popoola G, Hlongwa KN, Ndlovu H, Maes A, Vorster M, Sathekge MM. 68Ga-PSMA-11 PET/CT initial staging in black and white South African males with ISUP grade group 1 and 2 prostate adenocarcinoma. Biomedicines. 2022 Apr 12;10(4):882.
  14. Hlongwa KN, Mokoala KM, Matsena-Zingoni Z, Vorster M, Sathekge MM. The use of 18f-fdg pet/ct metabolic parameters in predicting overall survival in patients undergoing restaging for malignant melanoma. Diagnostics. 2022 Feb 25;12(3):595.
  1. Mpanya, D., Ayeni, A., More, S., Hadebe, B., Sathekge, M. and Tsabedze, N., 2021. The clinical utility of 2-deoxy-2-[18F] fluoro-d-glucose positron emission tomography in guiding myocardial revascularisation. Clinical and Translational Imaging, pp.1-14.
  2. Sathekge MM, Bruchertseifer F, Vorster M, Morgenstern A, Lawal IO. Global experience with PSMA-based alpha therapy in prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2021 Dec;49(1):30-46.
  • Harry, L., Nyakale, N. and Tinarwo, P., 2020. Scintigraphic peritoneography in the diagnosis of pleuroperitoneal leak complicating peritoneal dialysis: A comparison with conventional diagnostic methods. Medicine, 99(32).
  • Mody KG, Nyakale NE, Mutua SN, Anderson F. Gastrointestinal stromal tumours at Inkosi Albert Luthuli Central Hospital from 2005 to 2015. SA Journal of Oncology. 2019 Jan 1;3(1):1-8.
  • Rampursat Y, Bhimma R, Naicker E, Peer F,Gounden V. Evaluation of the revised Schwartz creatinine-based glomerular filtration rate estimating equation in Black African children in KwaZulu-Natal, South Africa. Annals of Clinical Biochemistry Annals of Clinical Biochemistry 2018, Vol. 55(4) 505–508.
  • Moodley N, Hariparshad S, Peer F, Gounden V. Evaluation of the CKD-EPI creatinine based glomerular filtration rate estimating equation in Black African and Indian adults in KwaZulu-Natal, South Africa. Clinical Biochemistry 59 (2018) 43–49.
  • Khan Z, Harry L, Msomi AP, Peer F, Nyakale NE. Assessing the diagnostic value of 90degree dynamic imaging for improved visualization of sentinel lymph nodes in breast cancer patients at Inkosi Albert Luthuli Central Hospital, 2017. World J Nucl Med. 2018; 17(4)
  • Lawal IO, Nyakale NE, Ankrah AO, Harry LM, Mokgoro NP, Msomi AP, Boshomane TMG, Van de Wiele C, Sathekge MM. F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Risk Assessment and Therapy response evaluation in patients with HIV-associated Hodgkin Lymphoma compared with HIV uninfected individuals. World J Nucl Med. 2018; 17(4)
  • Lawal IO, Ankrah AO, Popoola GO, Nyakale NE, Boshomane TMG, Reyneke F, Lengana T, Mariza Vorster M, Sathekge MM. F-18 FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma. Nucl Med Commun. 2018, 39:1005–1012
  • Lawal I, Louw L, Warwick J, Nyakale N, Steyn R, Lengana T, Ellmann A, Kotze T, Vangu M, Vorster M, Sathekge M. The College of Nuclear Physicians of South Africa Practice Guidelines on Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumours. S Afr J Surg 2018;56(3)
  • Mpikashe P, Nyakale N. PET-CT imaging of carcinoma of the oesophagus: The Kwa-Zulu Natal perspective. Eastern J of Medical Sciences. 2018; 3(4)
  • Nyakale N, Harry L, Ebrahim Dalais T, Pillay V. F-18 FDG PET/CT in the evaluation of response to treatment adjustment in recurrence and or progression of gastrointestinal stromal tumours. J Nucl Med, 2018; 59,supplement 1. 1407
  • Lawal I, Nyakale N, Lengana T, Harry L, Mokgoro N, Vorster M, Sathekge M. The role of higher pre-ablation serum thyroid stimulating hormone level in predicting effectiveness of radioiodine ablation of differentiated thyroid carcinoma. J Nucl Med. 2017;58 (Supple1):251.
  • Lawal IO, Nyakale NE, Harry LM, Lengana T, Mokgoro NP, Mariza Vorster M, Sathekge MM. Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma. Nucl Med Commun. 2017; 38:222–227
  • Lawal IO, Nyakale NE, Harry LM, Modiselle MR, Ankrah AO, Msomi AP, Mokgoro NP, Boshomane TG, Van de Wiele C, Sathekge MM. The role of F-18 FDG PET/CT in evaluating the impact of HIV infection on tumor burden and therapy outcome in patients with Hodgkin lymphoma. Eur J Nucl Med Mol Imaging 2017; 44:2025–2033
  • Muckart D, Hardcastle TC, Peer F. PET/CT Scanning for the Diagnosis of Occult Sepsis in the Critically Injured. SA Journal of Science March 2016 vol 54 no 1 (43-48).
  • Pleuroperitoneal leak: An unusual cause of acute shortness of breath in a peritoneal dialysis patient. D. P. Ramaema and P. Mpikashe., Volume 2014 (2014), Article ID 614846, 4 pages http://dx.doi.org/10.1155/2014/614846

BOOK CHAPTERS

  • Mody K, Peer F. Ultrasound, Magnetic Resonance Imaging and Positron Emission Tomography in the Evaluation of Colon Cancer. Chapter in CT Colonography for Radiographers – A Guide to Performance and Image Interpretation. Editors: Bortz J H, Ramlaul A, Munro L. Publisher: Springer International Publishing Switzerland 2016.
  • Peer F. Nuclear Medicine, Chapter 20, in Patient Centred Care. Editors: A Ramlaul and T Vosper. Publisher: Churchill Livingstone 2013.

CONFERENCE PROCEEDINGS

  • Kabunda J, Nyakale N. Diagnostic effects of benign lung changes in initial cancer staging with 18F FDG PET/CT, the KwaZulu-Natal experience. International Conference on Radiopharmaceutical Therapy 2020, Virtual event. 5-6 December 2020
  • Hadebe B, Nyakale N, Kabunda J, Harry L. Comparison of 68Ga-PSMA, 68Ga-DOTATATE and 18F-FDG accumulation in metastatic radioiodine refractory Hurthle cell variant of follicular thyroid carcinoma; a case report. International Conference on Radiopharmaceutical Therapy 2020, Virtual event. 5-6 December 2020
  • Nyakale N, Harry L, Hadebe B, Peer F. First experience with peptide receptor radionuclide therapying the KwaZulu-Natal state health-care sector. International Conference on Molecular Imaging and Clinical PET-CT in the Era of Theranostics (iPET-2020). 24-26 November 2020
  • Masikane S, Nyakale N. Efficacy of a fixed empirical radioiodine dose for Graves disease in poorly resourced region. 14th International Conference on radiopharmaceutical therapy, 21-25 August 2019
  • Peer F. The Role of the Radiographer in the Justification of Medical Exposure. Pan African Congress of Radiological Imaging, Accra, Ghana, 14-17 February 2019.
  • Khan Z, Harry L, Msomi AP, Peer F, Nyakale NE. Assessing the diagnostic value of 90degree dynamic imaging for improved visualization of sentinel lymph nodes in breast cancer patients at Inkosi Albert Luthuli Central Hospital, 2017. SASNM, Pretoria.
  • Lawal IO, Nyakale NE, Ankrah AO, Harry LM, Mokgoro NP, Msomi AP, Boshomane TMG, Van de Wiele C, Sathekge MM. F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Risk Assessment and Therapy response evaluation in patients with HIV-associated Hodgkin Lymphoma compared with HIV uninfected individuals. SASNM, Pretoria, 2018
  • Nyakale N, Harry L, Ebrahim Dalais T, Pillay V. F-18 FDG PET/CT in the evaluation of response to treatment adjustment in recurrence and or progression of gastrointestinal stromal tumours. SNMMI, USA.
  • Peer F. Optimization in Radiation Protection- a Radiographer’s Perspective. Chinese Congress of Radiology 2018. Beijing, China, 7-11 November 2018.
  • Lawal I, Nyakale N, Lengana T, Harry L, Mokgoro N, Vorster M, Sathekge M. The role of higher pre-ablation serum thyroid stimulating hormone level in predicting effectiveness of radioiodine ablation of differentiated thyroid carcinoma. SNMMI, USA.
  • Peer FI. Radiation Protection & Patient Safety Culture in Healthcare: An IAEA-WHO Initiative. Annual Radiology Meeting (ARM). Dubai, UAE, 6 November 2017
  • Peer FI. Role of a Radiographer in Authorisation -Justification –Optimisation. SA 2017 Imaging Congress, Durban South Africa, 3-5 November 2017
  • Peer FI. Ethics for Radiographers & Radiation Protection & Patient Safety Culture in Healthcare. IALCH, Durban, August 2017.
  • Peer FI. Teamwork in Radiography. 4th Diagnostic Imaging Course – ‘Risk Management for Radiography Technologist’, Kuwait 27-29 March 2017
  • Peer FI. Ethics in Radiography. 4th Diagnostic Imaging Course – ‘Risk Management for Radiography Technologist’, Kuwait 27-29 March 2017.
  • Peer FI. Role of the ISRRT & Response to the Bonn-Call-for-Action. Pan African Congress of Radiology and Imaging (PACORI), Dar-es-Salaam, Tanzania, February 2017
  • Msomi AP, Nyakale NE. F-18 FDG avid chief cell predominant adenoma with widespread brown tumours. SASNM, Pretoria, SA.
  • Peer FI. Radiation Safety Culture in Healthcare – Stakeholder’s Perspective: 5 Key Issues for Developing a Radiation Protection Culture in Medicine.3rd Regional IRPA- WHO – IOMP Workshop on Radiation Safety Culture in Healthcare: A Focus on Paediatric Radiology, Cape Town, South Africa, December 2016.
  • Peer FI. Radiation Safety Culture in Healthcare- A Global Perspective.3rd Regional IRPA- WHO – IOMP Workshop on Radiation Safety Culture in Healthcare: A Focus on Paediatric Radiology, Cape Town, South Africa, December 2016
  • Peer FI. The Role of the ISRRT in Integration, Innovation and Evolution. CSIT / CSR Joint Congress, Suzhou, China, October 2016.
  • Peer FI. ISRRT: Reflections of the Past & Looking Ahead. 32nd JART Congress, Gifu, Japan, September 2016.
  • Peer FI. ISRRT represents Radiographers globally. Congress of Korean Radiological Technologists Association. Seoul Korea, 30 October 2015.
  • Peer FI. The ISRRT: the voice of radiation medicine technology throughout the world. RSSA-SORSA Imaging Congress 2015. Johannesburg, 9 October 2015.
  • Peer FI. The ISRRT: Promoting Professional Practice. Antalya, Turkey 23 April 2015.
  • Peer FI. The ISRRT & Justification: Who is Responsible? BUSAN Catholic University, Busan, Korea, 3 November 2015.
  • Peer FI. ISRRT: Our vision is to promote the highest standards of patient care and professional practice… Trinidad, 13 April 2015.
  • Khan Z, Soni N. A rare presentation of diffuse large B cell lymphoma on F18 FDG PET/CT imaging. SASNM, Durban, SA.
  • Khan Z, Soni N. Peritoneal leak imaging in Nuclear Medicine. SASNM, Durban, SA.
  • Khan Z, Soni N. An unusual case of a neuroendocrine esophageal carcinoma on F18 FDG PET/CT imaging. SASNM, Durban, SA.
  • Pilloy WJ, Khan Z. Tc-99m EDDA Hynic TOC an alternative to In-111 DTPA Octreotide? SASNM, Durban, SA.
  • Peer FI. ISRRT: yesterday-today-tomorrow, TAMRT Congress, Taipei, November 2014.